Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs VBL vs Combination for Primary Prophylaxis of Variceal Bleeding
NCT02066649Phase 3Withdrawn
- Sponsor
- Rutgers University
- Start
- Jul 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in esophageal varices, Portal Hypertension (PH), sponsored by Rutgers University. Planned start Jul 2018; status: withdrawn.
02
Drugs
carvedilol
03
Conditions
esophageal varicesPortal Hypertension (PH)
Beyond the preview
Go deeper on NCT02066649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066649.